TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bio Visjon AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,729
|
1,641
|
1,690 |
| Financial expenses |
17
|
3
|
1 |
| Earnings before taxes |
82
|
110
|
160 |
| Total assets |
1,307
|
1,441
|
1,442 |
| Current assets |
571
|
622
|
606 |
| Current liabilities |
503
|
244
|
318 |
| Equity capital |
311
|
261
|
187 |
| - share capital |
8
|
9
|
9 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
23.8%
|
18.1%
|
13.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
4.7%
|
6.7%
|
9.5% |
| Return on assets (ROA) |
7.6%
|
7.8%
|
11.2% |
| Current ratio |
113.5%
|
254.9%
|
190.6% |
| Return on equity (ROE) |
26.4%
|
42.1%
|
85.6% |
| Change turnover |
172
|
59
|
-403 |
| Change turnover % |
11%
|
4%
|
-19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.